BioLineRx Ltd.
(NASDAQ : BLRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
0.33%84.1820.1%$581.82m
AMRNAmarin Corp. Plc
0.05%21.821.7%$311.99m
VRXValeant Pharmaceuticals International, Inc.
-0.86%28.7014.1%$168.87m
JAZZJazz Pharmaceuticals Plc
1.36%150.122.3%$100.75m
BHCBausch Health Cos., Inc.
-0.86%28.700.0%$100.38m
GWPHGW Pharmaceuticals Plc
-3.06%100.356.2%$98.60m
SAGESAGE Therapeutics, Inc.
7.04%64.428.6%$76.87m
ICPTIntercept Pharmaceuticals, Inc.
-9.81%108.0316.9%$75.74m
PRGOPerrigo Co. Plc
1.29%52.486.8%$70.89m
AXSMAxsome Therapeutics, Inc.
0.72%43.552.0%$52.24m
HZNPHorizon Therapeutics Plc
2.01%32.506.6%$45.62m
ICLRICON plc
0.82%162.724.2%$44.03m
ENDPEndo International Plc
1.14%4.888.8%$35.39m
UTHRUnited Therapeutics Corp.
1.77%91.8314.3%$34.07m
MYOKMyoKardia, Inc.
1.32%68.012.1%$30.40m

Company Profile

BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel.